14-50116518-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000395860.7(VCPKMT):c.35C>T(p.Pro12Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,613,344 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P12Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000395860.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCPKMT | NM_024558.3 | c.35C>T | p.Pro12Leu | missense_variant | 1/6 | ENST00000395860.7 | NP_078834.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCPKMT | ENST00000395860.7 | c.35C>T | p.Pro12Leu | missense_variant | 1/6 | 1 | NM_024558.3 | ENSP00000379201.2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000153 AC: 38AN: 247570Hom.: 0 AF XY: 0.000186 AC XY: 25AN XY: 134474
GnomAD4 exome AF: 0.000113 AC: 165AN: 1461006Hom.: 1 Cov.: 33 AF XY: 0.000116 AC XY: 84AN XY: 726752
GnomAD4 genome AF: 0.000118 AC: 18AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.35C>T (p.P12L) alteration is located in exon 1 (coding exon 1) of the VCPKMT gene. This alteration results from a C to T substitution at nucleotide position 35, causing the proline (P) at amino acid position 12 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at